Kristen Yen - Jul 27, 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Officer title: Vice President, Clinical Operations
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Stock symbol
SLNO
Transactions as of
Jul 27, 2022
Transactions value $
$0
Form type
4
Date filed
7/29/2022, 09:18 AM
Previous filing
Feb 1, 2022
Next filing
Oct 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Employee stock option (right to buy) Award $0 +200K $0.00 200K Jul 27, 2022 Common Stock 200K $0.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth of the shares subject to the option shall vest on August 1, 2022 and each three-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.

Remarks:

Officer title: Vice President, Clinical Operations